批判性推理CR-XMIW
出处: Manhattan-CAT-CR

A certain pharmaceutical firm recently developed a new medicine, Dendadrine, that provides highly effective treatment of severe stomach disorders that were previously thought to be untreatable. However, to develop the new medicine, the company spent nearly $5 billion in research and development costs. Given the size of the market for Dendadrine and the amount of the initial investment in its development, the company would need to sell Dendadrine at a price that is at least 5 times greater than its variable costs just to break even. Yet the company's management claims that Dendadrine will soon become the major driver of the firm's profits.

Which of the following statements best reconciles the management's claim with the evidence on the expenditures associated with the development of Dendadrine?
  • AThe pharmaceutical firm expects to be granted patent protection for Dendadrine; drugs under patent protection typically sell at prices that are approximately ten times their variable costs.

  • BThe development of some pharmaceutical products involves substantial initial expenditures on research, testing, and approval.

  • C In clinical tests, Dendadrine has proven far more effective at treating severe stomach disorders than any prior available treatments, without any serious side effects.

  • DNo competitors are developing or planning to develop new medicines that might compete with Dendadrine in the marketplace.

  • E Millions of people suffer from severe stomach disorders, representing an estimated one to two billion dollars every year in revenue.

显示答案
正确答案:A
报告错误题目

如果对题目有任何的疑惑,欢迎在这里提出来,大家会帮你解答的

    暂时没有找到与本题相关的帖子

      您需要登录后才可以回复 登录 | 立即注册

      表情

      欢迎使用GMAT学习系统

      考点归纳 透彻解析   助你各个击破

      知识扩展 查漏补缺   让你每分必争

      考题收录 全面权威   助你攻城略地

      模考系统 界面真实   让你如临其境

      备考记录 轨迹清晰   助你倍数前进

      复习打卡 全球同步   让你知己知彼

      反馈建议